You have searched for "Covaxin"
Showing 1-10 of 94
NEW DELHI (Reuters) -India will provide free COVID-19 vaccines to all adults, Prime Minister Narendra Modi said on Monday, in an effort to rein in a pandemic that has killed hundreds of thousands and led to the world's second-highest tally of infections.
India will have nearly 120 million doses of Covid-19 vaccines available for domestic use in June, the government said on Sunday.
Myanmar suspended some domestic flights and imposed restrictions in some townships to fight a surge in Covid cases in the past two days, the Ministry of Health and Sports said.
NEW DELHI (Reuters) -India on Thursday scrapped local trials for "well-established" foreign coronavirus vaccines to fast-track imports as it battles a devastating second wave of the pandemic that has killed tens of thousands of people.
NEW DELHI (Reuters) -India's official tally of daily infections of coronavirus fell to the lowest in nearly six weeks in the past 24 hours, offering hope that a devastating second wave is ebbing, but government leaders said shortages of vaccines were a big concern.
NEW DELHI (Reuters) -India has found 26 suspected cases of bleeding and clotting among recipients of the AstraZeneca vaccine, the health ministry said on Monday, describing the risk as "minuscule" out of the 164 million doses administered.
NEW DELHI (Reuters) -India's most populous state will spend up to $1.36 billion to buy COVID-19 shots and held early talks this week with companies such as Pfizer and the local partner of the maker of Russia's Sputnik V, a state official said on Thursday.
NEW DELHI (Reuters) - India recorded more than 4,000 COVID-19 deaths for a second straight day on Thursday as infections stayed below 400,000, and extended the interval between doses of the AstraZeneca vaccine to up to 16 weeks amid a dire shortage of shots in the country.
Type Namaste, the Indian greeting, and a WhatsApp chatbot asks the user’s zip code and instantly throws up a list of vaccination centers nearby. A search on Google Maps shows the route to the nearest clinic with vaccine availability.
NEW DELHI (Reuters) - India's Biological E. Ltd will soon start Phase III trials of its COVID-19 vaccine and plans producing 75 million to 80 million doses a month from August, its managing director told Reuters on Friday.